FINPROM Findings

2
low2026-02-02RNS 3600R
promotional_language
a leader in sustainable bioactive products and the Board believes that the Group is well positioned to capitalise on the global shift... pursuing transformative opportunities such as the potential treatment of septoria in wheat

Promotional terms ('well positioned', 'transformative') in a fundraising context, though partially qualified with 'the Board believes' and 'potential'. Issue price at a 2.6% premium to closing rather than a discount is notable positively. Director participation is modest and disclosed.

info2026-02-02RNS 3605R
positive_compliance
Issue Price represents a premium of approximately 2.6%... Past performance is not an indicator of future performance. Suffering a loss on your investment is always a possibility

Retail offer issued at a premium (not a discount), includes clear risk warnings, forward-looking disclaimers, and appropriate BookBuild platform disclosures. Good practice example of balanced retail offer documentation.

RNS Announcements

2
2026-02-023600R

Proposed Placing and Subscription

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.  PLEASE SEE THE IMPORTANT INFORMATION SECTION AT THE END OF THIS ANNOUNCEMENT. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO …

2026-02-023605R

Launch of Retail Offer

THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF EDEN RESEARCH PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORM…

Board of Directors

8
NameRoleAppointedStatus
Alex AbreyChief Financial Officeractive
Alexander John AbreyDirector2016-04-15active
Alexander John AbreyDirector2007-09-17active
Derek Ian McAllanNon-Executive Director2024-05-07active
Lykele Jurrit Van Der BroekDirector2017-10-01active
Lykele van der BroekNon-Executive Chairmanactive
Robin James Scott CridlandNon-Executive Director2015-05-08active
Sean Michael SmithChief Executive Officer2014-09-01active

Deal History

1
bookbuild2026-02-02£3.10m
2026-02-02proposed3600RProposed Placing and Subscription
2026-02-02result9386RResult of Retail Offer
2026-02-02retail offer3605RLaunch of Retail Offer